HIGH DENSITY LIPOPROTEIN CHOLESTEROL AS A PREDICTOR OF CARDIOVASCULAR DISEASE MORTALITY IN MEN AND WOMEN: THE FOLLOW-UP STUDY OF THE LIPID RESEARCH CLINICS PREVALENCE STUDY
- 1 January 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 131 (1) , 32-47
- https://doi.org/10.1093/oxfordjournals.aje.a115483
Abstract
With data from the Lipid Research Clinics Prevalence Study used as a baseline, an average of 8.4 years of mortality follow-up has been completed for 8,825 male and female participants who were at least 30 years of age at the time of the study. The participants were examined at 10 North American sites during 1972–1976. Univariate findings for high density lipoprotein (HDL) cholesterol in the 7,589 persons initially free of coronary heart disease indicate an inverse relation with cardiovascular disease mortality for men and women. Controlling for age, low density lipoprotein (LDL) cholesterol, triglycerides, body mass index, systolic blood pressure, and smoking, multivarlate analysis results indicate inverse relations between HDL cholesterol and cardiovascular disease mortality. In men, the cardiovascular disease mortality rate ratio for HDL cholesterol increments of 10 mg/dl was similar to the cardiovascular disease mortality rate ratio for LDL cholesterol increments of 30 mg/dl. In women, HDL cholesterol is more closely related to cardiovascular disease than is LDL cholesterol. HDL cholesterol is inversely related to both coronary heart disease and other cardiovascular disease mortality in both sexes, though the relation of HDL cholesterol with coronary heart disease mortality in women approached statistical significance only for the combined end point of suspect and definite cases. No relation was observed in either sex group between HDL cholesterol and noncardiovascular disease mortality. This study, only the second large prospective study evaluating the role of HDL cholesterol in women, confirms both the importance and the independence in both men and women of HDL cholesterol in the epidemiology of coronary heart disease and other cardiovascular disease mortality.Keywords
This publication has 12 references indexed in Scilit:
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.Circulation, 1986
- Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA, 1986
- Predictive value of the exercise tolerance test for mortality in North American men: the Lipid Research Clinics Mortality Follow-up Study.Circulation, 1986
- High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.BMJ, 1986
- Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.BMJ, 1985
- Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary deathThe American Journal of Cardiology, 1985
- HDL Serum Cholesterol and 24–Year Mortality of Men in FinlandInternational Journal of Epidemiology, 1984
- ALPHA LIPOPROTEIN (HDL) CHOLESTEROL IN THE SERUM AND THE RISK OF CORONARY HEART DISEASE AND DEATHThe Lancet, 1980
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977